Search Results - "POLAT, Bulent"

ZnO@Polypyrrole-P(VSANa) on flexible and wearable carbon felt as electrodes for nonenzymatic H2O2 sensor and supercapacitor applications by Polat, Bulent, Yazar, Sibel, Arvas, Melih Besir, Ozeroglu, Cemal

“…Herein, this work involves the synthesis and characterization of ZnO nanoparticles, which possess electroactive properties and are produced using an…”
Get full text

Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial by Kosmala, Rebekka, Fokas, Emmanouil, Flentje, Michael, Sauer, Rolf, Liersch, Torsten, Graeven, Ullrich, Fietkau, Rainer, Hohenberger, Werner, Arnold, Dirk, Hofheinz, Ralf-Dieter, Ghadimi, Michael, Ströbel, Philipp, Staib, Ludger, Grabenbauer, Gerhard G., Folprecht, Gunnar, Kirste, Simon, Uter, Wolfgang, Gall, Christine, Rödel, Claus, Polat, Bülent

“…The CAO/ARO/AIO trial has shown that oxaliplatin added to preoperative chemoradiotherapy and postoperative chemotherapy significantly improved disease-free…”
Get full text

27 years of experience with the Fontan procedure: characteristics and clinical outcomes of children in a tertiary referral hospital by Polat, Ahmet Bülent, Ertürk, Murat, Uzunhan, Ozan, Karademir, Nur, Öztarhan, Kazım

“…The Fontan operation has improved the survival of children born with congenital heart disease with single ventricle physiology. The most widely adopted…”
Get full text

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients by Hecht, Markus, Meier, Friedegund, Zimmer, Lisa, Polat, Bülent, Loquai, Carmen, Weishaupt, Carsten, Forschner, Andrea, Gutzmer, Ralf, Utikal, Jochen S, Goldinger, Simone M, Geier, Michael, Hassel, Jessica C, Balermpas, Panagiotis, Kiecker, Felix, Rauschenberg, Ricarda, Dietrich, Ursula, Clemens, Patrick, Berking, Carola, Grabenbauer, Gerhard, Schadendorf, Dirk, Grabbe, Stephan, Schuler, Gerold, Fietkau, Rainer, Distel, Luitpold V, Heinzerling, Lucie

“…Background: Concomitant radiation with BRAF inhibitor (BRAFi) therapy may increase radiation-induced side effects but also potentially improve tumour control…”
Get full text

Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial by Beck, Marcus, Sassowsky, Manfred, Schär, Sämi, Mathier, Etienne, Halter, Matthias, Zwahlen, Daniel R., Hölscher, Tobias, Arnold, Winfried, Polat, Bülent, Hildebrandt, Guido, Müller, Arndt-Christian, Putora, Paul M., Papachristofilou, Alexandros, Hayoz, Stefanie, Schär, Corinne, Li, Qiyu, Sumila, Marcin, Zaugg, Kathrin, Guckenberger, Matthias, Ost, Piet, Bosetti, Davide G., Reuter, Christiane, Gomez, Silvia, Khanfir, Kaouthar, Aebersold, Daniel M., Ghadjar, Pirus, Pra, Alan Dal

“…To evaluate the results of the radiation therapy (RT) quality assurance (QA) program of the phase 3 randomized SAKK 09/10 trial in patients with biochemically…”
Get full text

Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma by Wohlleben, Gisela, Hauff, Konstantin, Gasser, Martin, Waaga-Gasser, Ana Maria, Grimmig, Tanja, Flentje, Michael, Polat, Bülent

“…The plasma protein osteopontin (OPN) is considered to be a tumor biomarker, where elevated plasma levels are associated with poor prognosis. Additionally, OPN…”
Get full text

Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial by Diefenhardt, Markus, Martin, Daniel, Ludmir, Ethan B, Fleischmann, Maximilian, Hofheinz, Ralf-Dieter, Ghadimi, Michael, Kosmala, Rebekka, Polat, Bülent, Friede, Tim, Minsky, Bruce D, Rödel, Claus, Fokas, Emmanouil

“…Background: There is a lack of predictive models to identify patients at risk of high neoadjuvant chemoradiotherapy (CRT)-related acute toxicity in rectal…”
Get full text

Desynchronization of Cartesian k‐space sampling and periodic motion for improved retrospectively self‐gated 3D lung MRI using quasi‐random numbers by Weick, Stefan, Völker, Michael, Hemberger, Kathrin, Meyer, Cord, Ehses, Philipp, Polat, Bülent, Breuer, Felix A., Blaimer, Martin, Fink, Christian, Schad, Lothar R., Sauer, Otto A., Flentje, Michael, Jakob, Peter M.

“…Purpose To demonstrate that desynchronization between Cartesian k‐space sampling and periodic motion in free‐breathing lung MRI improves the robustness and…”
Get full text

Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis : serum levels and relationship to inflammation by DURSUNOGLU, Dursun, EVRENGÜL, Harun, POLAT, Bulent, TANRIVERDI, Halil, COBANKARA, Veli, KAFTAN, Asuman, KILIC, Mustafa

“…Changes in lipid profiles, Lp(a) lipoprotein, and acute phase reactants are associated with early atherosclerosis in rheumatoid arthritis (RA). The…”
Get full text

O-(2-[18F]fluoroethyl)-l-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy by Sweeney, Reinhart, Polat, Bülent, Samnick, Samuel, Reiners, Christoph, Flentje, Michael, Verburg, Frederik A.

“…Aim To evaluate the prognostic value of O -(2-[ 18 F]fluoroethyl)- l -tyrosine positron emission tomography (FET-PET) uptake intensity in World Health…”
Get full text

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12 by Fokas, Emmanouil, Allgäuer, Michael, Polat, Bülent, Klautke, Gunther, Grabenbauer, Gerhard G, Fietkau, Rainer, Kuhnt, Thomas, Staib, Ludger, Brunner, Thomas, Grosu, Anca-Ligia, Schmiegel, Wolff, Jacobasch, Lutz, Weitz, Jürgen, Folprecht, Gunnar, Schlenska-Lange, Anke, Flentje, Michael, Germer, Christoph-Thomas, Grützmann, Robert, Schwarzbach, Matthias, Paolucci, Vittorio, Bechstein, Wolf O, Friede, Tim, Ghadimi, Michael, Hofheinz, Ralf-Dieter, Rödel, Claus

“…Total neoadjuvant therapy is a new paradigm for rectal cancer treatment. Optimal scheduling of preoperative chemoradiotherapy (CRT) and chemotherapy remains to…”
Get full text

MAGE-A9 in head and neck cancer: Prognostic value and preclinical findings in the context of irradiation by Meyer, Till J, Hartmann, Stefan, Wohlleben, Gisela, Brisam, Muna, Seher, Axel, Kübler, Alexander C, Polat, Bülent, Müller-Richter, Urs D A

“…Radiotherapy alone, or as an addition to surgery is important for the treatment of head and neck squamous cell carcinoma (HNSCC). In addition to their…”
Get full text

Evaluation of the relationship between placentome perfusion, echotexture, and endocrine changes in cows at the end of pregnancy by Can Demi̇r, Murat, Kaçar, Cihan, Polat, Bülent

“…Although Doppler ultrasonography (USG) is frequently used in human medicine to evaluate placental function and fetal well-being, studies in veterinary medicine…”
Get full text

Health-related quality of life and clinical outcome after radiotherapy of patients with intracranial meningioma by Lisowski, Dominik, Trömel, Jannik, Lutyj, Paul, Lewitzki, Victor, Hartrampf, Philipp E., Polat, Bülent, Flentje, Michael, Tamihardja, Jörg

“…This retrospective, single-institutional study investigated long-term outcome, toxicity and health-related quality of life (HRQoL) in meningioma patients after…”
Get full text

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer by Tamihardja, Jörg, Cirsi, Sinan, Kessler, Patrick, Razinskas, Gary, Exner, Florian, Richter, Anne, Polat, Bülent, Flentje, Michael

“…Evaluation of delivered dose to the dominant intraprostatic lesion (DIL) for moderately hypofractionated radiotherapy of prostate cancer by cone beam computed…”
Get full text

Comparison of the postoperative outcome of the three-port laparoscopic ovariectomy and conventional open ovariectomy methods in dogs by Okur, Damla Tuǧçe, Polat, Bülent

“…The aim of this study is to determine the effects of laparoscopic ovariectomy (LOVE) and conventional open ovariectomy (COVE) methods on early-stage surgical…”
Get full text

The effects of low-level laser therapy on polycystic ovarian syndrome in rats: three different dosages by Polat, Bülent, Okur, Damla Tuğçe, Çolak, Armağan, Yilmaz, Kader, Özkaraca, Mustafa, Çomakli, Selim

“…The main objective of this in vivo study was to investigate the effect of different low-level laser therapy (LLLT) doses on polycystic ovary syndrome (PCOS)…”
Get full text

Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer—a two center experience by Mantel, Frederick, Müller, Elena, Kleine, Philip, Zimmermann, Marcus, Exner, Florian, Richter, Anne, Weick, Stefan, Ströhle, Serge, Polat, Bülent, Höcht, Stefan, Flentje, Michael

“…Purpose Integrating moderate hypofractionation to the macroscopic tumor with elective nodal irradiation while sparing the organs at risk (OAR) in…”
Get full text

Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma by Polat, Bülent, Wohlleben, Gisela, Kosmala, Rebekka, Lisowski, Dominik, Mantel, Frederick, Lewitzki, Victor, Löhr, Mario, Blum, Robert, Herud, Petra, Flentje, Michael, Monoranu, Camelia-Maria

“…Despite of a multimodal approach, recurrences can hardly be prevented in glioblastoma. This may be in part due to so called glioma stem cells. However, there…”
Get full text

Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings by Hummel, Horst-Dieter, Kufer, Peter, Grüllich, Carsten, Seggewiss-Bernhardt, Ruth, Deschler-Baier, Barbara, Chatterjee, Manik, Goebeler, Maria-Elisabeth, Miller, Kurt, de Santis, Maria, Loidl, Wolfgang, Dittrich, Christian, Buck, Andreas, Lapa, Constantin, Thurner, Annette, Wittemer-Rump, Sabine, Koca, Gökben, Boix, Oliver, Döcke, Wolf-Dietrich, Finnern, Ricarda, Kusi, Helena, Ajavon-Hartmann, Antoinette, Stienen, Sabine, Sayehli, Cyrus Michael, Polat, Bülent, Bargou, Ralf C

“… We report results of a first-in-human study of pasotuxizumab, a PSMA bispecific T-cell engager (BiTE ) immune therapy mediating T-cell killing of tumor cells…”
Get full text